Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 2, 2006, Pages 343-348

  Štrancar, Katja ^a   Blanot, Didier ^b   Gobec, Stanislav ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Antibacterials; Inhibitors; MurD

Indexed keywords

ARTICLE; STRUCTURE ACTIVITY RELATION;

BACTERIAL PROTEINS; DRUG DESIGN; ENZYME INHIBITORS; ESCHERICHIA COLI; MOLECULAR STRUCTURE; PEPTIDE SYNTHASES; PEPTIDOGLYCAN; PHOSPHINIC ACIDS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

ESCHERICHIA COLI;

EID: 27944446768     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.09.086     Document Type: Article

References (20)

1. P. Courvalin, and J. Davies Curr. Opin. Microbiol. 6 2003 425
2. H. Labischinski, and H. Maidhof J.-M. Ghuysen R. Hakenbeck Bacterial Cell Wall 1994 Elsevier Science B.V. Amsterdam 23
3. J. van Heijenoort Nat. Prod. Rep. 18 2001 503
4. F. Pratviel-Sosa, F. Acher, F. Trigalo, D. Blanot, R. Azerad, and J. van Heijenoort FEMS Microbiol. Lett. 115 1994 223
5. A. El Zoeiby, F. Sanschagrin, and R.C. Levesque Mol. Microbiol. 47 2003 1
6. M.E. Tanner, S. Vaganay, J. van Heijenoort, and D. Blanot J. Org. Chem. 61 1996 1756
7. L.D. Gegnas, S.T. Waddell, R.M. Chabin, S. Reddy, and K.K. Wong Bioorg. Med. Chem. Lett. 8 1998 1643
8. G. Auger, J. van Heijenoort, D. Blanot, and C. Deprun J. Prakt. Chem. 337 1995 351
9. S. Gobec, U. Urleb, G. Auger, and D. Blanot Pharmazie 56 2001 295
10. J.R. Horton, J.M. Bostock, I. Chopra, L. Hesse, S.E.V. Phillips, D.J. Adams, A.P. Johnson, and C.W.G. Fishwick Bioorg. Med. Chem. Lett. 13 2003 1557
11. Z. Li, G.D. Francisco, W. Hu, P. Labthavikul, P.J. Petersen, A. Severin, G. Singh, Y. Yang, B.A. Rasmussen, Y.-I. Lin, J.S. Skotnicki, and T.S. Mansour Bioorg. Med. Chem. Lett. 13 2003 2591
12. Snyder, N. J.; Tebbe, M. J.; Victor, F.; Blaszczak, L. C.; Halligan, N. G.; Sigmund, S.; Thompson, R. C.; Wilkie, S. C.; Stack, D. R.; Lee, C.; Birch, G. B.; Wu, C. E.; Smith, M. C. Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 26-29, San Francisco, USA, 1999; p 330.
13. Victor, F.; Tebbe, M. J.; Birch, G. B.; Smith, M. C.; Letourneau, D. L.; Wu, C. E. Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 26-29, San Francisco, USA, 1999; p 330.
14. M. Kotnik, M. Oblak, J. Humljan, S. Gobec, U. Urleb, and T. Šolmajer QSAR Comb. Sci. 23 2004 399
15. E.K. Baylis, C.D. Campbell, and J.G. Dingwall J. Chem. Soc., Perkin. Trans. 1 1984 2845
16. Bartlett, P. A.; Hanson, J. E.; Morgan, B. P.; Ellsworth, B. A. In Houben-Weyl: Synthesis of Peptides and Peptidomimetics, 4th ed.; Goodman, M., Ed.; Houben-Weyl Methods in Organic Chemistry; Thieme: Stuttgart, 2003; Vol. E22c, p 492.
17. 50 values were determined from a range of inhibitor concentrations; values ± standard deviations at 95% of confidence were calculated from the fitted regression equations using the logit-log plot.
18. G. Auger, L. Martin, J. Bertrand, P. Ferrari, E. Fanchon, S. Vaganay, Y. Pétillot, J. van Heijenoort, D. Blanot, and O. Dideberg Protein Expr. Purif. 13 1998 23
19. 2O: C, 48.54; H, 5.43; N, 3.14. Found: C, 48.75; H, 5.42; N, 2.99.
20. J.A. Bertrand, J. Auger, L. Martin, E. Fanchon, D. Blanot, D. Le Beller, J. van Heijenoort, and O. Dideberg J. Mol. Biol. 289 1999 579